Header Logo

Connection

Leslie Shaw to IMP Dehydrogenase

This is a "connection" page, showing publications Leslie Shaw has written about IMP Dehydrogenase.
Connection Strength

0.622
  1. Korecka M, Nikolic D, van Breemen RB, Shaw LM. The apparent inhibition of inosine monophosphate dehydrogenase by mycophenolic acid glucuronide is attributable to the presence of trace quantities of mycophenolic acid. Clin Chem. 1999 Jul; 45(7):1047-50.
    View in: PubMed
    Score: 0.163
  2. Nowak I, Shaw LM. Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity. Ther Drug Monit. 1997 Jun; 19(3):358-60.
    View in: PubMed
    Score: 0.141
  3. Nowak I, Wu J, Brayman KL, Shaw LM. Is the glucuronide metabolite of MPA pharmacologically active? Transplant Proc. 1997 Feb-Mar; 29(1-2):337.
    View in: PubMed
    Score: 0.138
  4. Brandhorst G, Marquet P, Shaw LM, Liebisch G, Schmitz G, Coffing MJ, Domke I, Streit F, Luthe H, Oellerich M. Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma. Ther Drug Monit. 2008 Aug; 30(4):428-33.
    View in: PubMed
    Score: 0.077
  5. Kaplan B, Meier-Kriesche HU, Friedman G, Mulgaonkar S, Gruber S, Korecka M, Brayman KL, Shaw LM. The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol. 1999 Jul; 39(7):715-20.
    View in: PubMed
    Score: 0.041
  6. Shaw LM, Sollinger HW, Halloran P, Morris RE, Yatscoff RW, Ransom J, Tsina I, Keown P, Holt DW, Lieberman R, et al. Mycophenolate mofetil: a report of the consensus panel. Ther Drug Monit. 1995 Dec; 17(6):690-9.
    View in: PubMed
    Score: 0.032
  7. Nowak I, Shaw LM. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem. 1995 Jul; 41(7):1011-7.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.